What is the difference between BAM15 and Glutathione?

BAM15: BAM15 is a synthetic small-molecule mitochondrial uncoupler (protonophore) — not a peptide — studied preclinically for obesity and metabolic disease as a potentially safer alternative to DNP. It has n... Glutathione: Glutathione is an endogenous tripeptide (gamma-L-glutamyl-L-cysteinyl-glycine) that serves as the principal intracellular antioxidant in mammalian cells. It is not FDA-approved as a drug in the US; pa...

What does the research say about BAM15 vs Glutathione?

BAM15: In diet-induced obese mice, BAM15 reduced fat mass and improved insulin sensitivity without changing food intake or lean mass (Nature Communications 2020); other mouse work shows benefit in diabetes, and in sepsis/acute kidney injury. Rodent PK is ~67% oral bioavailability with a ~1.7 h half-life; there is no human PK, safety, or dosing data. Not a… Glutathione: A randomized, double-blind pilot trial (Hauser et al., Movement Disorders, 2009, PMID 19230029) tested IV glutathione 1,400 mg three times weekly for 4 weeks in Parkinson's disease (n=21); it was well tolerated but did NOT show a statistically significant effect on UPDRS scores. A large randomized trial of inhaled glutathione (646 mg every 12 hours…

BAM15 vs Glutathione

Q: Can you stack BAM15 and Glutathione?

BAM15 (metabolic) and Glutathione (immune) are in different categories and are sometimes researched together in combined protocols. Consult a licensed provider before combining any compounds.

Head-to-head comparison of BAM15 and Glutathione — mechanism, side effects, legal status, and pricing.

BAM15

BAM15 is a synthetic small-molecule mitochondrial uncoupler (protonophore) — not a peptide — studied preclinically for obesity and metabolic disease as a potentially safer alternative to DNP. It has never been tested in humans, has no regulatory approval, and was added to the WADA Prohibited List as an AMPK activator. It is sold as a gray-market research chemical.

Profile Prices Testing

Glutathione

Glutathione is an endogenous tripeptide (gamma-L-glutamyl-L-cysteinyl-glycine) that serves as the principal intracellular antioxidant in mammalian cells. It is not FDA-approved as a drug in the US; parenteral glutathione is used off-label (and in some compounding settings) for oxidative stress, hepatic support, and — controversially — skin lightening. The FDA has warned against injectable glutathione for skin lightening (2019) due to reports of serious adverse events.

Profile Prices Testing

BAM15

Glutathione

Category

Metabolic

Immune

Legal Status

Research Only

Mechanism

BAM15 increases proton permeability of the inner mitochondrial membrane, letting protons leak back into the matrix independent of ATP synthase — dissipating the proton-motive force and uncoupling electron transport from ATP synthesis, which raises substrate oxidation and heat production. Unlike DNP/FCCP it does not depolarize the plasma membrane at fully-uncoupling doses and is less cytotoxic than FCCP; downstream it activates AMPK (Kenwood et al., 2014). All data are cell/animal.

Glutathione cycles between reduced (GSH) and oxidized (GSSG) forms, donating electrons to reactive oxygen species via glutathione peroxidase. It serves as a cofactor for glutathione S-transferases (GSTs) in Phase II detoxification, maintains reduced protein thiols, supports T-cell proliferation and NK cell cytotoxicity, and regenerates vitamins C and E. Proposed skin-lightening activity is attributed to inhibition of tyrosinase and a shift from eumelanin toward phaeomelanin synthesis, though clinical evidence is limited and largely from small Asian dermatology trials.

Side Effects

No human safety data — BAM15 has never been tested in humans
Class risk of mitochondrial uncouplers (as with DNP): dangerous hyperthermia and metabolic disruption at excess doses
WADA-prohibited at all times (S4, AMPK activator; added to the 2026 list)

Where Researchers Are Buying

Live · updated daily

COA-verified vendors · trust score ≥70 required · single-vial price — bulk/bundle deals may be lower

BAM15

Best $/mg

$0.020/mg

Kimera ChemsC

1 trusted vendor listing

Compare all 1 vendor

Glutathione

Best $/mg

$0.023/mg

Peptide Supply Co.B

11 trusted vendors listing

Compare all 11 vendors

Lab Verification

COA corpus from Disclosed Labs — independently tested batches only.

BAM15

COAs

99.1%

Avg purity

Labs

Full testing data

Glutathione

COAs

99.5%

Avg purity

Labs

Full testing data

BAM15 Research Summary

In diet-induced obese mice, BAM15 reduced fat mass and improved insulin sensitivity without changing food intake or lean mass (Nature Communications 2020); other mouse work shows benefit in diabetes, and in sepsis/acute kidney injury. Rodent PK is ~67% oral bioavailability with a ~1.7 h half-life; there is no human PK, safety, or dosing data. Not approved; not a peptide.

Key references

Glutathione Research Summary

A randomized, double-blind pilot trial (Hauser et al., Movement Disorders, 2009, PMID 19230029) tested IV glutathione 1,400 mg three times weekly for 4 weeks in Parkinson's disease (n=21); it was well tolerated but did NOT show a statistically significant effect on UPDRS scores. A large randomized trial of inhaled glutathione (646 mg every 12 hours for 6 months) in cystic fibrosis (Griese et al., Am J Respir Crit Care Med, 2013, PMID 23631796) did not demonstrate clinically relevant improvements in lung function, exacerbations, or quality of life. Oral glutathione has poor bioavailability due to GI degradation, driving investigation of IV, nebulized, liposomal, and sublingual delivery. The FDA issued a 2019 warning about compounded sterile injectable glutathione made from dietary-grade ingredient, citing adverse-event reports (including Stevens-Johnson syndrome, toxic epidermal necrolysis, and kidney dysfunction) particularly in the context of unregulated IV skin-lightening use.

Key references

Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease (Hauser et al., Movement Disorders) (2009)

Can you stack BAM15 and Glutathione?

BAM15 (Metabolic) and Glutathione (Immune) are in different categories and target different biological pathways. This is a common pattern in multi-compound research protocols. Researchers should monitor the biomarkers from both profiles and watch for interactions listed in each compound’s contraindications. Consult a licensed healthcare provider before combining any research compounds.

Other comparisons

Glutathione vs MOTS-c BAM15 vs MOTS-c AOD-9604 vs Glutathione AOD-9604 vs BAM15 5-Amino-1MQ vs Glutathione 5-Amino-1MQ vs BAM15 Glutathione vs NAD+BAM15 vs NAD+

This platform provides informational tools only, not medical advice. This comparison is for educational purposes only. Consult a licensed provider.